Osteoporosis in chronic liver disease

Risk of secondary osteoporosis due to lobular cholestasis in non-cirrhotic primary biliary cholangitis

(2017) Anna Seki et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Sclerostin Expression in Bile Ducts of Patients With Chronic Cholestasis May Influence the Bone Disease in Primary Biliary Cirrhosis

(2016) Núria Guañabens et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Osteoporosis in liver disease: pathogenesis and management

(2016) Gabriela Handzlik-Orlik et al.   Therapeutic Advances in Endocrinology and Metabolism

A Common Variant in CLDN14 is Associated with Primary Biliary Cirrhosis and Bone Mineral Density

(2016) Ruqi Tang et al.   Scientific Reports

Ursodeoxycholic acid decreases bilirubin-induced osteoblast apoptosis

(2014) Silvia Ruiz-Gaspà et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Bone Disease in Patients Awaiting Liver Transplantation. Has the Situation Improved in the Last Two Decades?

(2013) Ana Monegal et al.   CALCIFIED TISSUE INTERNATIONAL

Randomized trial comparing monthly ibandronate and weekly alendronate for osteoporosis in patients with primary biliary cirrhosis

(2013) Núria Guañabens et al.   HEPATOLOGY

Vitamin K and Bone Health

(2013) Maryam S. Hamidi et al.   JOURNAL OF CLINICAL DENSITOMETRY

Ursodeoxycholic acid increases differentiation and mineralization and neutralizes the damaging effects of bilirubin on osteoblastic cells

(2013) Marta Dubreuil et al.   LIVER INTERNATIONAL

Review article: non-alcoholic fatty liver disease and osteoporosis - clinical and molecular crosstalk

(2012) Y. Yilmaz   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Zoledronic AcidVersusAlendronate for the Prevention of Bone Loss after Heart or Liver Transplantation

(2012) Elizabeth Shane et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Association between Nonalcoholic Fatty Liver Disease (NAFLD) and Osteoporotic Fracture in Middle-Aged and Elderly Chinese

(2012) Mian Li et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The evaluation of bone mineral density in patients with nonalcoholic fatty liver disease

(2012) Tugrul Purnak et al.   WIENER KLINISCHE WOCHENSCHRIFT

Effects of bilirubin and sera from jaundiced patients on osteoblasts: Contribution to the development of osteoporosis in liver diseases

(2011) Silvia Ruiz-Gaspà et al.   HEPATOLOGY

Parenteral Bisphosphonates for Osteoporosis in Patients With Primary Biliary Cirrhosis

(2010) Sombat Treeprasertsuk et al.   AMERICAN JOURNAL OF THERAPEUTICS

Bone loss caused by iron overload in a murine model: importance of oxidative stress

(2010) J. Tsay et al.   BLOOD

Low Bone Mass and Severity of Cholestasis Affect Fracture Risk in Patients With Primary Biliary Cirrhosis

(2010) Núria Guañabens et al.   GASTROENTEROLOGY

Bone Disease in Patients With Primary Sclerosing Cholangitis

(2010) Paul Angulo et al.   GASTROENTEROLOGY

Effects of testosterone and venesection on spinal and peripheral bone mineral in six hypogonadal men with hemochromatosis

(2010) Terrence Diamond et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Bone mass improves in alcoholics after 2 years of abstinence

(2010) Pilar Peris et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis

(2010) Felicia Cosman et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Musculoskeletal Complications of Hereditary Hemochromatosis: A Case-Control Study

(2010) P. RICHETTE et al.   JOURNAL OF RHEUMATOLOGY

Primary biliary cirrhosis is associated with falls and significant fall related injury

(2010) J. Frith et al.   QJM-AN INTERNATIONAL JOURNAL OF MEDICINE

Lithocholic acid downregulates vitamin D effects in human osteoblasts

(2009) S. Ruiz-Gaspà et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

High osteoprotegerin serum levels in primary biliary cirrhosis are associated with disease severity but not with the mRNA gene expression in liver tissue

(2009) Núria Guañabens et al.   JOURNAL OF BONE AND MINERAL METABOLISM

Bone Mineral Density and Serum Levels of Soluble Tumor Necrosis Factors, Estradiol, and Osteoprotegerin in Postmenopausal Women with Cirrhosis after Viral Hepatitis

(2009) Jorge L. González-Calvin et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Current understanding of osteoporosis associated with liver disease

(2009) Inaam A. Nakchbandi et al.   Nature Reviews Gastroenterology & Hepatology

Osteoporosis in chronic liver disease: a case–control study

(2009) Ghizlane Wariaghli et al.   RHEUMATOLOGY INTERNATIONAL

Excess iron inhibits osteoblast metabolism

(2009) Kanako Yamasaki et al.   TOXICOLOGY LETTERS

Association Between Alcohol Consumption and Both Osteoporotic Fracture and Bone Density

(2008) Karina M. Berg et al.   AMERICAN JOURNAL OF MEDICINE

Short-Term Effects of High-Dose Zoledronic Acid Treatment on Bone Mineralization Density Distribution After Orthotopic Liver Transplantation

(2008) B. M. Misof et al.   CALCIFIED TISSUE INTERNATIONAL

Osteoporosis in Primary Biliary Cirrhosis: Pathogenesis and Treatment

(2008) Albert Parés et al.   Clinics in Liver Disease

Isoform of Fibronectin Mediates Bone Loss in Patients With Primary Biliary Cirrhosis by Suppressing Bone Formation

(2008) Nina Kawelke et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Association between iron overload and osteoporosis in patients with hereditary hemochromatosis

(2008) L. Valenti et al.   OSTEOPOROSIS INTERNATIONAL

Pamidronate in the prevention of bone loss after liver transplantation: a randomized controlled trial

(2008) Ana Monegal et al.   TRANSPLANT INTERNATIONAL

Human Parathyroid Hormone 1–34 Prevents Bone Loss in Experimental Biliary Cirrhosis in Rats

(2007) Rivka Dresner–Pollak et al.   GASTROENTEROLOGY